MedTrace Logo

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

NCT00489346 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 994

Last updated 2024-08-15

No results posted yet for this study

Summary

A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.

Conditions

  • Asthma, Bronchial

Interventions

DRUG

MK0476, montelukast sodium / Duration of Treatment: 1 Year

DRUG

Comparator : fluticasone propionate / Duration of Treatment: 1 Year

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2002-06-30
Completion
2002-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00489346 on ClinicalTrials.gov